Literature DB >> 9381740

Medical Grand Rounds: refractory hypertension and renal insufficiency in a patient with renal artery stenosis.

S J Huot1, L M Scoutt, G H Meier.   

Abstract

Renal artery stenosis has become increasingly common as a cause of refractory hypertension and renal insufficiency. There is a high prevalence of bilateral disease and the lesions tend to progress over time. Newer, less invasive, imaging modalities such as doppler ultrasound, magnetic resonance angiography, and spiral CT scanning are evolving technologies in the diagnosis of renal artery stenosis. Advances in surgical technique, particularly the development of extra-anatomical procedures such as spleno-renal and hepato-renal by pass, have significantly lowered surgical morbidity and mortality and provides revascularization options for patients with complex vascular disease that would previously not have been considered because of their high surgical risk. Improvements in angioplasty technique and the use of stents are broadening the types of lesions that can be successfully approached with these techniques and may be particularly helpful for patients with more severe cardiac or cerebrovascular disease. The benefits of revascularization may be even greater for preservation of renal function than for control of blood pressure in properly selected patients. It is difficult to predict which patients will benefit from surgical revascularization versus medical management of RAS. Knowledge of the progressive nature of RAS, the high prevalence of bilateral disease, and the clinical characteristics that correlate with progression (e.g., decreasing renal size) are helpful in guiding clinical decisions regarding intervention. Additional studies to determine the predictive value of non-invasive tests such as CRS, doppler ultrasound before and after administration of angiotensin converting enzyme inhibitors, and other tests, are needed to assist the clinician in identifying who will benefit most from revascularization both in terms of renal function and blood pressure control.

Entities:  

Mesh:

Year:  1996        PMID: 9381740      PMCID: PMC2588999     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  31 in total

1.  Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation.

Authors:  D C Taylor; M D Kettler; G L Moneta; T R Kohler; A Kazmers; K W Beach; D E Strandness
Journal:  J Vasc Surg       Date:  1988-02       Impact factor: 4.268

2.  Clinical course of atherosclerotic renovascular disease.

Authors:  J Wollenweber; S G Sheps; G D Davis
Journal:  Am J Cardiol       Date:  1968-01       Impact factor: 2.778

3.  Natural history of renal arterial disease.

Authors:  T F Meaney; H P Dustan; L J McCormack
Journal:  Radiology       Date:  1968-11       Impact factor: 11.105

4.  Noninvasive diagnosis of renal artery stenosis by ultrasonic duplex scanning.

Authors:  T R Kohler; R E Zierler; R L Martin; S C Nicholls; R O Bergelin; A Kazmers; K W Beach; D E Strandness
Journal:  J Vasc Surg       Date:  1986-11       Impact factor: 4.268

5.  Renal artery stenosis: prospective evaluation of diagnosis with color duplex US compared with angiography. Work in progress.

Authors:  L L Berland; D B Koslin; W D Routh; F S Keller
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

6.  Renal duplex sonography: evaluation of clinical utility.

Authors:  K J Hansen; R W Tribble; S W Reavis; V J Canzanello; T E Craven; G W Plonk; R H Dean
Journal:  J Vasc Surg       Date:  1990-09       Impact factor: 4.268

7.  The natural history of atherosclerotic and fibrous renal artery disease.

Authors:  M J Schreiber; M A Pohl; A C Novick
Journal:  Urol Clin North Am       Date:  1984-08       Impact factor: 2.241

Review 8.  Atherosclerotic renovascular disease and progressive renal failure.

Authors:  J M Rimmer; F J Gennari
Journal:  Ann Intern Med       Date:  1993-05-01       Impact factor: 25.391

9.  Captopril renography in the diagnosis of renal artery stenosis: accuracy and limitations.

Authors:  S J Mann; T G Pickering; T A Sos; R G Uzzo; S Sarkar; K Friend; M E Rackson; J H Laragh
Journal:  Am J Med       Date:  1991-01       Impact factor: 4.965

10.  Renovascular hypertension: anatomic and renal function changes during drug therapy.

Authors:  R H Dean; R W Kieffer; B M Smith; J A Oates; J H Nadeau; J W Hollifield; W D DuPont
Journal:  Arch Surg       Date:  1981-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.